Bank of Nova Scotia
MDCO

Bank of Nova Scotia’s Medicines Co MDCO Stock Holding History

Bank of Nova Scotia’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-15,500
Closed -$511K – 984
2018
Q1 		$511K Sell
15,500
-201,500
-93% -$6.3M ﹤0.01% 806
2017
Q4 		$5.93M Buy
+217,000
New +$6.68M 0.03% 383

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Bank of Nova Scotia's MDCO Position: Q2 2018 in Review

Bank of Nova Scotia sold out of Medicines Co (MDCO) in Q2 2018, closing a stake of 15,500 shares — an estimated $511K sold.

Bank of Nova Scotia first reported a position in MDCO in Q4 2017 and held it in 2 quarters. The position peaked at $5.93M in Q4 2017. 188 funds tracked by Wall St. Rank hold MDCO as of Q2 2018.

  • Bank of Nova Scotia reported no remaining Medicines Co position as of Q2 2018 after selling out during the quarter.
  • Bank of Nova Scotia sold 15,500 Medicines Co shares in Q2 2018, an estimated $511K.
  • Bank of Nova Scotia first reported a position in Medicines Co in Q4 2017 and held it in 2 quarters.
  • Bank of Nova Scotia's Medicines Co position peaked at $5.93M in Q4 2017.
  • 188 funds tracked by Wall St. Rank held Medicines Co as of Q2 2018.

Based on Bank of Nova Scotia's 13F filing for Q2 2018, filed 14 Aug 2018.